Salute e Benessere
EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion
Cyted's technology has already demonstrated significant success across the UK's National Health Service, completing over 35,000 tests and building a robust portfolio of peer-reviewed publications proving unmatched patient acceptability and real-world clinical impact.
"This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier," said Marcel Gehrung , CEO and Co-founder of Cyted Health. "This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio."
Bruno Holthof , Partner at EQT Life Sciences, commented: "Cyted is strongly positioned to redefine the standard of care in upper GI diagnostics worldwide. Its minimally invasive diagnostics platform is the standout innovation to capture this significant market opportunity, and we're delighted to add the company to our portfolio."
Founded by leading experts at the University of Cambridge , Cyted is pioneering the development of minimally invasive cell collection coupled with proprietary biomarker discovery to transform the detection of pre-cancerous, cancerous, and inflammatory esophageal conditions.
Cyted's Series B financing round follows the recent expansion of its advisory panel to establish a Clinical Advisory Board. The Board comprises leading clinicians and researchers in gastroenterology and oncology who will provide strategic guidance as Cyted builds its advanced diagnostics portfolio and widens its footprint in the US.
EQT Press Office, press@eqtpartners.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/eqt-life-sciences-leads-usd-44-million-series-b-financing-in-cyted-health-to-accelerate-us-expansion,c4228125
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/eqt-life-sciences-leads-usd-44-million-series-b-financing-in-cyted-health-to-accelerate-us-expansion-302543628.html